NEW YORK (Reuters Health) – Longer-term follow-up data from the MINDACT trial confirm the clinical utility of the 70-gene MammaPrint assay to help guide chemotherapy decisions in women with early breast cancer, but also suggests that age may be a…
Read More
Could Tamoxifen Dose Be Slashed Down to 2.5 mg?
Tamoxifen has long been used in breast cancer, both in the adjuvant and preventive setting, but uptake and adherence are notoriously low, mainly because of adverse events. Using a much lower dose to reduce the incidence of side effects would…
Read More
Cancer Warning Labels on Alcohol: Calls for Congress to Act
At a time when Americans are drinking more alcohol than ever before, a group of health organizations is lobbying Congress for a new cancer-specific warning label to be displayed on all alcoholic beverages. The new wording would read: “WARNING: According…
Read More